Portuguese schizophrenic patients can't afford treatment 

Long-acting injectable antipsychotics are the best treatment available for this mental health disorder, but at 50€ per month, they are too expensive for many.

Catia Bruno
Catia Bruno NewsMavens, Portugal
Portuguese schizophrenic patients can't afford treatment  - NewsMavens
Pills, PixaBay

Why this story matters:

Schizophrenia is a mental disorder that affects only 1% of the population, but its symptoms and effects can be severe. The distortions in thinking that come with the disease can lead to hallucinations and abnormal behaviour that can disturb others and, more importantly, severely impact a sufferer’s life.

That is why medication is so crucial to ensure a good quality of life for both patients and those around them. In spite of this need, since 2010 Portugal has stopped fully subsidizing long-acting injectable antipsychotics such as Fluanxol and Xeplion, which have proved to be most effective in reducing schizophrenia symptoms. 

This means that patients will now have to pay for 5% or 10% of the medication -- a sum that may reach around 50€ per injection.

Many of these patients don’t hold a steady job and subsist on meagre state pensions. As if this wasn’t enough, schizophrenia patients often don’t recognize that they have a severe mental health problem and refuse medication. The fact that they have to pay such a high cost per month leads many to refuse treatment entirely.

Details from the story:

  • Long-acting injectable antipsychotics have less side effects, unlike the old and cheaper medication that can make patients slow and unable to function.
  • Psychiatrists are worried about the situation, speaking out for their patients who abandon the medication. The Portuguese Medical Association claims this kind of medication should be entirely subsidized, since these patients have “terrible levels in therapeutic compliance” and are not able to “come together to protest” about the situation.
  • João Marques Teixeira, chairman of the Portuguese Psychiatry and Mental Health Society, underlined the stigma and economic challenges the families of these patients face and criticized the fact that other mental health patients are able to have 100% subsidized medication while schizophrenics are not.
  • The Portuguese National Authority of Medicines (INFARMED) states that there are no plans to alter the subsidizing regime.
inbox_large_illu Created with Sketch.
Tired of the news media’s prevailing male perspective? We are too.

Get our newsletters composed exclusively by female journalists from all over Europe.


Project #Femfacts co-financed by European Commission Directorate-General for Communications Networks, Content and Technology as part of the Pilot Project – Media Literacy For All

The information and views set out on this website are those of the author(s) and do not necessarily reflect the official opinion of the European Union. Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein.

NewsMavens is a media start-up within Gazeta Wyborcza, Poland's largest liberal broadsheet published by Agora S.A. NewsMavens is currently financed by Gazeta Wyborcza and Google DNI Fund.
Is something happening in your country that Newsmavens should cover?
Zuzanna Ziomecka
Zuzanna Ziomecka EDITOR IN CHIEF
Lea Berriault-Jauvin
Lea Berriault Managing Editor
Jessica Sirotin
Jessica Sirotin EDITOR
Ada Petriczko
Ada Petriczko EDITOR
Gazeta Wyborcza, Agora SA Czerska 8/10 00-732, Warsaw Poland
The e-mail addresses provided above are not intended for recruitment purposes. Messages concerning recruitment will be deleted immediately. Your personal data provided as part of your correspondence with Zuzanna,Lea, Jessica and Ada will be processed for the purpose of resolving the issue you contacted us about. The data provided in your email is controlled by Agora S.A. with its registered office in Warsaw Czerska 8/10 Street (00-732). You can find more information about the processing and protection of your personal data at https://newsmavens.com/transparency-policy